Minimizing UV noise in supercritical fluid chromatography. I. Improving back pressure regulator pressure noise

被引:48
作者
Berger, Terry A. [1 ]
Berger, Blair K. [1 ]
机构
[1] Aurora SFC Syst Inc, Redwood City, CA 94063 USA
关键词
Supercritical fluid chromatography (SFC); Back pressure regulator (BPR); Refractive index (RI); UV detector noise; Pressure noise; Validation; PACKED-COLUMN SFC; DRUG DISCOVERY; AQUEOUS FORMULATION; CHIRAL SEPARATION; DIRECT ASSAY; SUBSTANCE; PURIFICATION; ENANTIOMERS; VALIDATION; IMPURITY;
D O I
10.1016/j.chroma.2011.02.030
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Pressure fluctuations and resulting refractive index changes, induced by the back pressure regulator (BPR) can be a significant source of UV detector noise in supercritical fluid chromatography (SFC). The refractive index (RI) of pure carbon dioxide (CO2) changes approximate to 0.2%/bar at the most commonly used conditions in supercritical fluid chromatography (SFC) (40 degrees C and 100 bar), compared to 0.0045%/bar for water (CO2 IS 44x worse). Changes in RI cause changes in the focal length of the detector cell which results in changes in UV intensity entering the detector. The change in RI (Delta RI/bar) of CO2 decreases 8-fold at 200 bar, compared to 100 bar. A new back pressure regulator (BPR) design representing an order of magnitude improvement in the state of the art is shown to produce peak to peak pressure noise (PNp-p) as low as 0.1 bar, at 200 bar, and 20 Hz, compared to older equipment that attempted to maintain PNp-p < 1 bar, at <5 Hz. With this lower PNp-p, changes in baseline UV offsets could be measured as a function of very small changes in pressure. A pressure change of +/- 1 bar at 100 bar, common with some older BPR's, produced a UV baseline offset >0.5 mAU. A pressure change of +/- 0.5 bar representing the previous state-of-the-art, resulted in a UV offset of 0.3 mAU. Baseline noise <0.05 is required to validate methods for trace analysis. The new BPR, with a PNp-p of 0.1 bar. demonstrated UV peak to peak noise (Np-p) < 0.02 mAU with a >0.03 min (10 Hz) electronic filter under some conditions. This new low noise level makes it possible to validate SFC methods for the first time. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:2320 / 2326
页数:7
相关论文
共 28 条
[1]   Packed-column SFC in the pharmaceutical industry: cGMP aspects [J].
Anton, K ;
Siffrin, C .
ANALUSIS, 1999, 27 (08) :691-701
[2]   Demonstrative validation study employing a packed column pressurized fluid chromatography method that provides assay, achiral impurities, chiral impurity, and IR identity testing for a drug substance [J].
Ashraf-Khorassani, M ;
Taylor, LT ;
Williams, DG ;
Roston, DA ;
Catalano, TT .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (5-6) :725-738
[3]  
Berger T. A., 1991, J HIGH RES CHROMATOG, V14, P312
[4]  
BERGER TA, 2009, PEAK ON LINE EDITION
[5]  
BERGER TA, MINIMIZING UV UNPUB, V2
[6]   Nature of the main contaminant in the drug primaquine diphosphate: SFC and SFC-MS methods of analysis [J].
Brondz, Ilia ;
Ekeberg, Dag ;
Bell, David S. ;
Annino, Amy R. ;
Hustad, Jan Arild ;
Svendsen, Robert ;
Vlachos, Vaso ;
Oakley, Paul ;
Langley, G. John ;
Mohini, Thite ;
Amaury, Cazenave-Gassiot ;
Mikhalitsyn, Felix .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 43 (03) :937-944
[7]   Using subcritical/supercritical fluid chromatography to separate acidic, basic, and neutral compounds over an ionic liquid-functionalized stationary phase [J].
Chou, Fu-Min ;
Wang, Wei-Ting ;
Wei, Guor-Tzo .
JOURNAL OF CHROMATOGRAPHY A, 2009, 1216 (16) :3594-3599
[8]   Dielectric and volumetric properties of supercritical carbon dioxide(1) plus methanol(2) mixtures at 323.15 K [J].
Goldfarb, DL ;
Fernández, DP ;
Corti, HR .
FLUID PHASE EQUILIBRIA, 1999, 158 :1011-1019
[9]   Packed column supercritical fluid chromatography of a peroxysome proliferator-activating receptor agonist drug - Achiral and chiral purity of substance, formulation assay and its enantiomeric purity [J].
Gyllenhaal, O .
JOURNAL OF CHROMATOGRAPHY A, 2004, 1042 (1-2) :173-180
[10]  
Gyllenhaal O., 2000, PROG PHARM BIOMED AN, P382